Navigation Links
JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM)
Date:2/27/2008

CHARLESTON, S.C., Feb. 27 /PRNewswire/ -- JSJ Pharmaceuticals is pleased to announce the introduction of its new aesthetic division, Vitivia(TM). Vitivia(TM) will focus on medically based aesthetics and utilize the clinical roots of JSJ Pharmaceuticals in the development of science-based, result-oriented products.

Vitivia(TM)'s first product introduction will be its Pro:Vitamin line. Topical vitamins have long been recognized as important tools in the anti-aging process. The benefits of most topical vitamins, however, have been limited by the inability to stabilize vitamins when exposed to air and light. For products that have attempted to address this stability issue, long lists of preservative agents have been the answer. Vitivia(TM)'s Pro:Vitamin has found an innovative solution to these challenges.

In light of the fact that today's consumers desire natural ingredients, free of chemical preservatives, fragrances, coloring, or other allergens, Vitivia(TM)'s Pro:Vitamin line combines pure concentrations of natural ingredients with the best of modern science. This formulation is then placed in individual biodegradable unit dose packaging insuring each application of Pro:Vitamin has never been exposed to light or air. As a result, the concentration of the first application is as pure and stable as the last.

"With the continued growth of medically based aesthetics, Vitivia(TM) will be an important growth factor for the future of JSJ Pharmaceuticals," stated JSJ's Chief Operating Officer, Jonathan Alba. "The introduction of the clinically proven Pro:Vitamin line will be a key part of the long-term foundation of the Vitivia(TM) division of JSJ," stated Alba.

Vitivia(TM)'s Pro:Vitamin line is available through physician offices nationally. For more information regarding the purchase or distribution of Vitivia(TM) products visit http://www.Vitivia.com or call 1-888-975-4848.

About
'/>"/>

SOURCE JSJ Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
2. NPS Pharmaceuticals Announces Senior Management Changes
3. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
4. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
5. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
7. Nycomed US Inc. Acquires Bradley Pharmaceuticals, Inc.
8. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
9. Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
10. Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split
11. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Sterlitech Corporation ... its comprehensive line of analytical laboratory equipment. With optimized features, such as PTFE-coated ... a chemically resistant and maintenance-free solution for a broad range of vacuum filtration ...
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce ... Lyon County Fair to be held August 5-9 in Marshall. The Ralco Enrichment Center ... come from and how agriculture impacts their daily lives. This unique exhibit also features ...
(Date:7/30/2015)... 2015 According to a new ... Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract ... Trial), by End Users - Global Forecast to 2020", ... reach USD 2,107.99 million by 2020 from USD 1,034.93 ... Browse more than 75 ...
(Date:7/30/2015)... Denmark , July 30, 2015 ... biotechnology company that applies its innovative TransCon technology ... positive top-line results from a six-month Phase 2 ... once-weekly TransCon Growth Hormone in 53 treatment-naïve, pre-pubertal ... "We are extremely pleased with the top-line ...
Breaking Biology Technology:Sterlitech Launches New Line of Vacuum Pumps 2Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... NEWARK, Del., Feb. 19 Lightwave Logic, Inc. (OTC ... technology company focused on the development of electro-optic polymer ... optical computing, announced today the addition of Anthony J. ... for 30 years in medicinal chemistry and brings a ...
... - finally accepts legitimate call by shareholders to general ... - will not allow shareholder ... - persists with high risk, high funding, Avexa merger proposal. ... Meeting scheduled for 27 March 2009 MELBOURNE, Australia, Feb. 19 ...
... solar cell materials that are as abundant but much ... today could substantially reduce the cost of solar photovoltaics, ... Resources Group and the Department of Chemistry at the ... Laboratory (LBNL). , These materials, some of which ...
Cached Biology Technology:Lightwave Logic, Inc. Announces the Addition of Anthony J. Cocuzza, PhD to its Technology Team 2Progen Concedes Shareholder Requisitioned Meeting 2Progen Concedes Shareholder Requisitioned Meeting 3Progen Concedes Shareholder Requisitioned Meeting 4Progen Concedes Shareholder Requisitioned Meeting 5Cheaper materials could be key to low-cost solar cells 2Cheaper materials could be key to low-cost solar cells 3
(Date:7/21/2015)... Today, ZTE announced its Android smartphone Axon, featuring FPC,s ... in 2015 that relate to sales of FPC1025 for this smartphone ... MSEK for 2015. Jörgen Lantto, CEO of FPC, comments: ... China and we are proud that ... Axon , its first smartphone ...
(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... Stanford,s Jasper Ridge Biological Preserve often encounter signs of ... deer carcass covered with leaves. But few have actually ... images captured by remote wildlife cameras confirm that mountain ... to Stanford,s 1,189-acre preserve in the hills five miles ...
... regarded as hostile for wildlife and urbanization a dramatic ... far from dead zones. Their biodiversity may even exceed ... frequent localization in naturally rich areas that historically supplied ... definitely the case of the city of Prague, Czech ...
... Anemia type II (CDA II) is a rare blood disorder, ... will surprise you is the fact that some mutations responsible ... study led by the ENERCA member Prof. Achille Iolascon ... of Naples Federico II, analyzes two mutations (E109K and R14W) ...
Cached Biology News:Learning to live in mountain lion country 2Prague's 88 nature reserves threatened by invasive plant species 2Study tracks mutations causing CDA II back to the Roman Empire 2Study tracks mutations causing CDA II back to the Roman Empire 3
Anti-Conjugated Quinaldic Acid...
... The Dodeca silver stain kits ... staining devices including Bio-Rad Dodeca stainers. ... nanogram quantities of proteins in polyacrylamide ... The kit includes sensitizer concentrate, silver ...
The AVR9-8 stream-select valve is a 9-port, 8-position valve for use with the BioLogic DuoFlow system. This valve is used for high-pressure stream selection....
... Miscellaneous: Versatile stain for staining RNA (bluish-purple), DNA (blue), ... TLC ≥ 90 % Cation traces: Ca ≤ ... mg/kg Cr ≤ 5 mg/kg Cu ≤ 5 mg/kg ... ≤ 5 mg/kg Mn ≤ 5 mg/kg Na ≤ ...
Biology Products: